EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotoxicity effects in Cancer Patients: Evaluation by Micronucleus and Comet Assays and Correlation with Biochemical and Hematological Indices

Sarab Dalaf Khalaf, Atyaf Talal Mahmood, Alyaa Fadhil Abbas, Ruwaida Watheq Neamah, Rana Nasser Abdul Hameed

F1000Research · 17.07.2026 · 15 · 545

DOI: 10.12688/f1000research.178233.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 17.07.2026. Verfasst von Sarab Dalaf Khalaf und 4 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer is one of the most significant global health challenges. Cytogenetic techniques are used as biomarkers of cancer risk to detect DNA damage and chromosomal abnormalities.

Objective

This study aimed to evaluate the influence of chemotherapy on genetic stability in cancer patients by applying Micronucleus and Comet assays as indicators of DNA and chromosomal alterations. It also aimed to determine the possible links between these genotoxic changes and variations in biochemical and hematological parameters, providing insight into the cellular responses to chemotherapy exposure.

Methods

Buccal epithelial cells were collected from 190 individuals (90 controls and 100 cancer patients) and stained for micronucleus analysis. To observe DNA breakdown, cells from blood were subjected to an alkaline comet assay. Biochemical (urea, creatinine, calcium, and bilirubin) and hematopoietic (Hb, WBC, Plt, and HCT) parameters were also assessed.

Results

Cancer patients showed elevated Binucleated cell (27.50 ± 3.62),Condensed chromatin (10.50 ± 2.87), broken eggs (2.65 ± 1.53), basal cell (4.65 ± 1.98), Karyorrhetic cell (9.45 ± 1.73), Karyolytic cell(85.10 ± 2.69), Monoonucleated cell with Micronucleus(12.50 ± 1.43), and Percentage of nuclear anomalies in total(152.8 ± 4.75) compared with controls. The comet assay results revealed pronounced DNA fragmentation in cancer cells, with variable tail lengths indicating heterogeneous damage. The biochemical results showed a significant increase in the mean levels of urea (50.600 ± 8.259) and creatinine (1.073 ± 0.173), and no significant increase in TSB (0.917 ± 0.143) and HCT(38.080 ± 2.311) in cancer patients compared to the control. Calcium (9.010 ± 0.680), Hb (8.322 ± 1.247), Plt (91.300 ± 24.495), and WBC (11.920 ± 2.833) levels were lower in the patient group than in the control group.

Conclusion

The increased frequency of nuclear anomalies and DNA fragmentation in cancer patients highlights the potential of the buccal Micronucleus assay and comet assays as effective, non-invasive tools for early cancer detection and genotoxic monitoring. Alterations in the blood and biochemical parameters further support the systemic effects of malignancy.

Zitieren

APA

Khalaf, S. D., Mahmood, A. T., Abbas, A. F., Neamah, R. W., & Hameed, R. N. A. (2026). Genotoxicity effects in Cancer Patients: Evaluation by Micronucleus and Comet Assays and Correlation with Biochemical and Hematological Indices. F1000Research, 15, 545. https://doi.org/10.12688/f1000research.178233.2

Vancouver

Khalaf SD, Mahmood AT, Abbas AF, Neamah RW, Hameed RNA. Genotoxicity effects in Cancer Patients: Evaluation by Micronucleus and Comet Assays and Correlation with Biochemical and Hematological Indices. F1000Research. 2026;15:545. doi:10.12688/f1000research.178233.2

BibTeX
@article{Khalaf2026,
  author = {Khalaf, Sarab Dalaf and Mahmood, Atyaf Talal and Abbas, Alyaa Fadhil and Neamah, Ruwaida Watheq and Hameed, Rana Nasser Abdul},
  title = {Genotoxicity effects in Cancer Patients: Evaluation by Micronucleus and Comet Assays and Correlation with Biochemical and Hematological Indices},
  journal = {F1000Research},
  year = {2026},
  volume = {15},
  pages = {545},
  doi = {10.12688/f1000research.178233.2}
}
Kostenlos starten →